Current Cancer Drug Targets
Volume 21, 11 Issues, 2021
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
ISSN: 1873-5576 (Online)
ISSN: 1568-0096 (Print)
This journal supports open access
Contents
Current Cancer Drug Targets, Volume 15 - Number 3
COMMENTARY: Pre-emptive Nutrition: Refining the Targets of Drugs Targeted to Colorectal Cancer
, 15(3): 173 - 175Lynnette R. Ferguson and William A. Denny
DOI: 10.2174/156800961503150505120604
MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells
, 15(3): 176 - 187Yan Chen, Fan Feng, Xudong Gao, Chunping Wang, Huiwei Sun, Cuihong Zhang, Zhen Zeng, Yinying Lu, Linjing An, Jianhui Qu, Fusheng Wang and Yongping Yang
DOI: 10.2174/1568009615666150225122635
MiRNA153 Reduces Effects of Chemotherapeutic Agents or Small Molecular Kinase Inhibitor in HCC Cells
Modulation by Licofelone and Celecoxib of Experimentally Induced Cancer and Preneoplastic Lesions in Mice Exposed to Cigarette Smoke
, 15(3): 188 - 195Roumen Balansky, Gancho Ganchev, Marietta Iltcheva, Manasi Nikolov, Sebastiano La Maestra, Rosanna T. Micale, Francesco D'Agostini, Vernon E. Steele and Silvio De Flora
DOI: 10.2174/1568009615666150216170008
Modulation by Licofelone and Celecoxib of Experimentally Induced Cancer and Preneoplastic Lesions in Mice Exposed to Cigarette Smoke
Dual Inhibition of Cdc7 and Cdk9 by PHA-767491 Suppresses Hepatocarcinoma Synergistically with 5-Fluorouracil
, 15(3): 196 - 204Wei Li, Xiao-Le Zhao, Shi-Qiang Shang, Hong-Qiang Shen and Xi Chen
DOI: 10.2174/1568009615666150212112753
Dual Inhibition of Cdc7 and Cdk9 by PHA-767491 Suppresses Hepatocarcinoma Synergistically with 5-Fluorouracil
Targeting Microparticle Biogenesis: A Novel Approach to the Circumvention of Cancer Multidrug Resistance
, 15(3): 205 - 214Ariane Roseblade, Frederick Luk, Alison Ung and Mary Bebawy
DOI: 10.2174/1568009615666150225121508
Targeting Microparticle Biogenesis: A Novel Approach to the Circumvention of Cancer Multidrug Resistance
Co-targeting EGFR and Autophagy Impairs Ovarian Cancer Cell Survival during Detachment from the ECM
, 15(3): 215 - 226Zongyuan Yang, Yi Liu, Xiao Wei, Xiaoshui Zhou, Cheng Gong, Taoran Zhang, Ping Jin, Sen Xu, Ding Ma and Qinglei Gao
DOI: 10.2174/1568009615666150126161939
Co-targeting EGFR and Autophagy Impairs Ovarian Cancer Cell Survival during Detachment from the ECM
Transposable Elements in Cancer and Other Human Diseases
, 15(3): 227 - 242Benoit Chenais
DOI: 10.2174/1568009615666150317122506
Transposable Elements in Cancer and Other Human Diseases
Present, Emerging and Possible Future Biomarkers in Castration Resistant Prostate Cancer (CRPC)
, 15(3): 243 - 255Martin Boegemann, Andres-Jan Schrader, Laura-Maria Krabbe and Edwin Herrmann
DOI: 10.2174/1568009615666150204145803
Present, Emerging and Possible Future Biomarkers in Castration Resistant Prostate Cancer (CRPC)
Cancer Stem Cells in Solid and Liquid Tissues of Breast Cancer Patients: Characterization and Therapeutic Perspectives
, 15(3): 256 - 269Rena Chiotaki, Hara Polioudaki and Panayiotis A. Theodoropoulos
DOI: 10.2174/1568009615666150211102503
Cancer Stem Cells in Solid and Liquid Tissues of Breast Cancer Patients: Characterization and Therapeutic Perspectives
Editor-in-Chief
Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
(USA)
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
COPE Compliant
About the Journal
For Authors
For Librarians & Readers
Quick Links
Journal History
Current Cancer Drug Targets was launched in 2001. Dr. Ruiwen Zhang serves as the Editor-in-Chief of the journal.
Advertisement
Webmaster Contact: info@benthamscience.net